Cas no 1202564-31-5 (2-Chlorodibenzof,hquinoxaline)
2-Chlorodibenzof,hquinoxaline structure
Product Name:2-Chlorodibenzof,hquinoxaline
CAS No:1202564-31-5
MF:C16H9ClN2
MW:264.709062337875
MDL:MFCD28405117
CID:1016535
PubChem ID:58019496
Update Time:2025-04-20
2-Chlorodibenzof,hquinoxaline Chemical and Physical Properties
Names and Identifiers
-
- 2-chlorodibenzo[f,h]quinoxaline
- 1202564-31-5
- CS-0441986
- 2-chlorophenanthro[9,10-b]pyrazine
- 2-Chlorodibenzo-(f,h)-quinoxaline
- FEYJCWNQZBKYKT-UHFFFAOYSA-N
- DB-104515
- AMY7278
- 2-Chloro-Dibenzo[f,h]Quinoxaline
- Dibenzo[f,h]quinoxaline,2-chloro-
- 3-chlorophenanthro[9,10-b]pyrazine
- SB67087
- AKOS027253908
- AS-40539
- MFCD28405117
- SCHEMBL284801
- 2-Chlorodibenzof,hquinoxaline
-
- MDL： MFCD28405117
- Inchi： 1S/C16H9ClN2/c17-14-9-18-15-12-7-3-1-5-10(12)11-6-2-4-8-13(11)16(15)19-14/h1-9H
- InChI Key： FEYJCWNQZBKYKT-UHFFFAOYSA-N
- SMILES： ClC1=CN=C2C(C3C=CC=CC=3C3C=CC=CC=32)=N1
Computed Properties
- Exact Mass: 264.0454260g/mol
- Monoisotopic Mass: 264.0454260g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 19
- Rotatable Bond Count: 0
- Complexity: 335
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.8
- Topological Polar Surface Area: 25.8?2
2-Chlorodibenzof,hquinoxaline Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A019099520-5g |
2-Chlorodibenzo[f,h]quinoxaline |
1202564-31-5 | 95% | 5g |
$865.34 | 2023-09-04 | |
| TRC | C365283-10mg |
2-Chlorodibenzo[f,h]quinoxaline |
1202564-31-5 | 10mg |
$ 50.00 | 2022-04-01 | ||
| TRC | C365283-50mg |
2-Chlorodibenzo[f,h]quinoxaline |
1202564-31-5 | 50mg |
$ 115.00 | 2022-04-01 | ||
| TRC | C365283-100mg |
2-Chlorodibenzo[f,h]quinoxaline |
1202564-31-5 | 100mg |
$ 160.00 | 2022-04-01 | ||
| abcr | AB457135-250 mg |
2-Chlorodibenzo[f,h]quinoxaline |
1202564-31-5 | 250mg |
€194.90 | 2023-04-22 | ||
| abcr | AB457135-1 g |
2-Chlorodibenzo[f,h]quinoxaline |
1202564-31-5 | 1g |
€535.60 | 2023-04-22 | ||
| Chemenu | CM141935-5g |
2-chlorodibenzo[f,h]quinoxaline |
1202564-31-5 | 95% | 5g |
$660 | 2022-12-28 | |
| abcr | AB457135-250mg |
2-Chlorodibenzo[f,h]quinoxaline; . |
1202564-31-5 | 250mg |
€197.30 | 2025-02-14 | ||
| abcr | AB457135-1g |
2-Chlorodibenzo[f,h]quinoxaline; . |
1202564-31-5 | 1g |
€543.50 | 2025-02-14 | ||
| abcr | AB457135-5g |
2-Chlorodibenzo[f,h]quinoxaline; . |
1202564-31-5 | 5g |
€1511.80 | 2025-02-14 |
2-Chlorodibenzof,hquinoxaline Related Literature
-
Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
-
Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
-
Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
-
Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
1202564-31-5 (2-Chlorodibenzof,hquinoxaline) Related Products
- 2213-63-0(2,3-Dichloroquinoxaline)
- 62196-37-6(Benzo[f][1,7]naphthyridine, 3-chloro-)
- 13058-77-0(8-Chloro-1,7-naphthyridine)
- 59489-31-5(2,7-Dichloroquinoxaline)
- 18671-97-1(2,6-Dichloroquinoxaline)
- 1448-87-9(2-Chloroquinoxaline)
- 62140-99-2(Benzo[f][1,7]naphthyridine, 5-chloro-)
- 29176-55-4(2,9-Dichloro-1,10-phenanthroline)
- 7089-68-1(2-Chloro-1,10-phenanthroline)
- 62141-01-9(Benzo[f][1,7]naphthyridine, 3,5-dichloro-)
Recommended suppliers
Shanghai Hongxiang Biomedical Technology Co., Ltd.
Gold Member
Audited Supplier
CN Supplier
Bulk
Hangzhou Cedareal Technology Co., Ltd.
Gold Member
Audited Supplier
CN Supplier
Bulk
Nanjing Jubai Biopharm
Gold Member
Audited Supplier
CN Supplier
Bulk
TAIXING JOXIN BIO-TEC CO.,LTD.
Gold Member
Audited Supplier
CN Supplier
Bulk
上海帛亦醫(yī)藥科技有限公司
Gold Member
Audited Supplier
CN Supplier
Reagent